Trial reportScientific reports2026
Eggshell powder as a biomimetic alternative to biodentine in primary teeth pulpotomy: a comparative clinical and radiographic study.
Trial report in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05812053 (Comparative Evaluation of Eggshell Powder Versus Biodentine in Primary Teeth Pulpotomy), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Comparative Evaluation of Eggshell Powder Versus Biodentine in Primary Teeth Pulpotomy: Clinical And Radiographic Study
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eggshell powder (EP) has been suggested as a cost-effective pulpotomy material due to its high biocompatibility, remineralization potential, and ability to induce dentin bridge formation. This study compared the clinical and radiographic outcomes of EP, Biodentine, and mineral trioxide aggregate (MTA) when used as pulpotomy agents in primary molars. A randomized split-mouth clinical trial was performed on 30 children, each receiving pulpotomy in 3 primary molars assigned to Group I (EP), Group II (Biodentine), and Group III (MTA), with 30 teeth per group. Clinical evaluations were carried out at baseline, 3-, 6-, and 12-month. Cone-beam computed tomography (CBCT) scans were performed immediately postoperatively and at 12- month to evaluate root resorption and radiodensity changes. All groups demonstrated 100% clinical success within 3-month. At 12-month, Group I showed significantly higher rates of spontaneous pain, abnormal mobility, fistula, and internal and external root resorption (p < .05). CBCT analysis revealed significantly lower radiodensity values in Group I compared with Groups II and III. Group III (MTA) exhibited the most favorable radiographic outcomes, followed by Group II (Biodentine). EP achieved acceptable short-term results; however, its long-term performance was inferior to MTA and Biodentine.Clinical significance EP represents a low-cost, biocompatible, and environmentally sustainable biomaterial derived from recycled natural waste. Despite its eco-friendly and biomimetic advantages, its long-term clinical and radiographic performance remained inferior to Biodentine and MTA, which continue to be the more reliable pulpotomy materials for primary molars.Trial registration NCT05812053, "ComparativeEvaluation of Eggshell Powder in Primary Teeth Pulpotomy", https://clinicaltrials.gov/ . Registered: 2023/04/13.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.